ABSTRACT. Expression plasmids containing human interleukin-2(IL-2) cDNA under the control of viral promoters (SV40 early region, MuLV LTR, HTLV-I LTR, and ASV(Y73) LTR) were introduced into TK-mouse L cells and human FL cells to establish IL-2 producing cells. The highest levels of IL-2 producing clones were obtained in TK+ mouse L cells transformed with a recombinant plasmid having MuLV LTR as a promoter, whereas transformed cells of human FL cells (G418r) were revealed to produce IL-2 at the highest level when the cells were transfected with a plasmid containing HTLV LTR as a promoter. These results suggest that these promoter/enhancer regions possess different cell specificities in gene expression. To obtain higher levels of IL-2 production using gene amplification, the hybrid plasmids containing the hamster DHFR and human IL-2 genes were constructed and transfected into DHFR-CHO cells. DHFR+ colonies produced IL-2 at about the same level as that produced by TK+ L cells transformed with the recombinants containing MuLV LTR. Selection of methotrexate-resistant cells resulted in a 5-to 30-fold increase of IL-2 production. These cells produced IL-2 stably for at least 3 months, even in the absence of methotrexate.
Studies on and the use of the physiologically active proteins are, in many cases, hampered by the limited amounts of the purified substance. Recombinant DNA technology is now widely used to produce such proteins, for instance, interferons, lymphokines and growth factors, in prokaryotes in high amounts. However, many of these secretary proteins from natural sources receive post-transcriptional modifications, such as glycosylation, which are not performed by prokaryotes. Several systems (7, 38) have been developed to express cloned DNA in mammalian cells, in which the resulting proteins are believed to be glycosylated and secreted. To obtain established cell lines that express the introduced foreign genes at high levels, the most suitable promoter-vector system has to be used for each host cell type. Furthermore, the gene amplification procedures have been known to be rather effective for obtaining a high level of gene expression (12, 16, 25, 31) .
Here, we report the comparative studies on the suitable promoters for the expression of cDNA of human IL-2, a lymphokine which plays an essential role in immunoregulatory networks (3, 28) in mouse or human cells, and the establishment of cell lines which constitutively synthesize and secrete human IL-2. We also describe the expression of this gene in CHO cells by using two kinds of amplifiable vectors. 
RESULTS
Transformation of TK-mouse L cells with expression plasmids. TK-mouse L cells were transfected with the recombinant plasmids using a 50-fold excess of IL-2 Fig. 3 . IL-2 activity in culture medium produced by clones of mouse L TK+ transformants. Cells were grown to reach about 80 % confluent in 24 well plates and the medium was changed to 1 ml of fresh MEM containing 10% FCS per well. After cultivation for 48 h, the culture supernatant was collected and assayed for IL-2 activity. IL-2 activity was measured by stimulating the growth of NKC3 cells as described in MATERIALS AND METHODS. Each bar indicates IL-2 activity of the culture supernatant of each clone (22 dilution) by % absorbance of the maximum stimulation. When over 50 % stimulation was observed, units of IL-2 were calculated, and are shown above each bar.
expression plasmids (Fig. 1 ) over the pTK61 carrying the cloned HSV TK gene (38) . TK+ clones (10 to 20 per 106 transfected cells) were obtained after two weeks. Culture supernatants of individual transformed clones were collected 48 h after the cells were 80 % confluent (about 106 cells/ml) and were assayed for human IL-2 activity. Figure 3 shows the activity of IL-2 produced by TK+ L cell individual clones transformed with IL-2 expression plasmids directed by various promoters. Among 9 transformed clones obtained with pTB106 directed by the SV40 early-region promoter (L-IL106), IL-2 activity was detected in the culture medium of 7 clones. Clone 4 (L-IL106-4) showed the highest production of IL-2 (0.6 units/ml), but most clones produced 0.01 to 0.1 units/ml of IL-2. In comparison, almost all clones transformed with pTB314 containing MuLV LTR as a promoter (L-IL314) produced over • of activity, at most. In 2 of 8 clones of transformants with pTB 106 (SV40 early-region promoter), IL-2 activity of up to 0.1 units/ml was detected ; no activity was detected in any of the transformants with pTB401 (ASV-Y73 LTR) (Fig. 4) . The results on the IL-2 production of various L cell transformed clones in comparison with that of human FL cells are summarized in Fig. 5 . In a preliminary experiment, 4 recombinant plasmids, pTB106, pTB314, pTB385 and pTB401, were introduced into DHFRhamster CHO cells with the expression plasmid of DHFR cDNA, pTB348. The DHFR-f-transformants which appeared on one dish (10-50 colonies) were mixed and cultured. Much more IL-2 production (about 0.3 to 1 units/ml) was observed in the case of pTB314 (MuLV LTR) and pTB385 (HTLV LTR) than that with pTB106 (0.1 to 0.2 units/rill) or pTB401 (<0.05 units/m1). Hence, the promoter activity of MuLV LTR or HTLV LTR seems to be stronger than that of SV40 early-region promoter or ASV LTR in CHO cells. Southern blotting analyses of L cell transformants. Cellular DNAs of L cell transformants were digested with HindIII or BamHI, and the IL-2 genes were analyzed using the Southern blotting with 32P-labeled IL-2 cDNA as a probe (Fig. 6) . The hybridization patterns and visual concentration of autoradiographs indicated that most L cell transformants had multiple insertions of IL-2 cDNA accompanied by rearrangements. In addition, there seems to be a correlation between the copy number and ability for IL-2 production in the transformants : among the transformants with the same recombinant plasmids, the more copies of IL-2 cDNA there were, the greater the IL-2 activity. In contrast, the clone, L-IL314-12, transformed with pTB314 (MuLV LTR) and shown to have the highest level of IL-2 production, had fewer copies than the transformants with pTB106 (SV40 early), pTB385 (HTLV LTR-IL-2), and pTB401 (ASV-Y73 LTR). These results suggest that IL-2 production in the transformants depends on promoter activity and copy number, at least.
Transformation of CHO cells with two amplifiable plasmids. It has been reported that a high level of gene expression was observed with amplifiable vectors; for example, MTX has been used as a means to amplify the newly introduced genes with the DHFR gene (12, 25) . Figure 2 illustrates the construction of two kinds of DHFR gene-linked hybrid plasmids for expressing human IL-2 cDNA in CHO cells. One of them, pTB485, carries two complete transcription units in tandem arrangement, that is, IL-2 gene expression directed by MuLV LTR and DHFR gene expression the presence of [35S] methionine, and the labeled proteins in the medium were analyzed on SDS-polyacrylamide gel electrophoresis using immunoprecipitation against anti-human IL-2 serum. Two bands at the position corresponding to MW of 14 Kd (minor band) and 17 Kd (major band) were observed in the sample from C-IL485-14 cells, but not in the control sample (Fig. 8) . The molecular size is different from that calculated from the deduced amino acid sequence (MW 15 Kd), but is similar to the size of natural human IL-2 produced by peripheral blood lymphocytes (15 The transformation frequency with pTB487 was less than one-tenth that with pTB485. The plasmid pTB487 carries IL-2 and DHFR cDNA in a tandem alignment under the control of MuLV LTR as a promoter (polycistronic construction). The low frequency of transformation (DHFR+) might be caused by the low transcriptional level of DHFR gene. Among the transformants with pTB487, a high producer clone, C-IL487-10 (10 units/ml), was obtained. But the selection of MTX-resistant cells was not as effective as it was with the transformants with pTB485.
C-IL485-14 cells, a clone of MTX-resistant cells selected from C-IL485-4 cells, produced about 30-fold more IL-2 than did the original clone. Southern blotting analyses of these clones suggest that the increase seems to be caused by amplification of the DHFR gene accompanied by the IL-2 gene, as reported elsewhere (12, 16, 25) . The IL-2 accumulated in culture fluid of C-IL485-14 cells reached as much as 120 units/ml. This corresponds to 3 to 4 µg/ml of IL-2 protein. The production of IL-2 in this MTX-resistant clone was stable for several months, even if MTX was omitted from the medium.
SDS-polyacrylamide gel electrophoresis of secreted proteins from several CHO transformants revealed at least two bands with mobilities corresponding to 17 kd and 14 kd after immunoprecipitation with anti-human IL-2 anti-serum. In L and FL transformed cells, similar results were also obtained, except that much more of the 14 kd band was observed (about one-third of the 17 kd band) in L cell transformants (data not shown). The molecular values of the immunoprecipitates coincided well with those of natural human IL-2 produced from peripheral blood lymphocytes (15) . Hence, both bands seem to represent the human IL-2 polypeptides processed and glycosylated. Recently, Conradt et al. reported that transformed mouse L cells and CHO cells, with a plasmid containing human genomic IL-2 gene, secreted IL-2 of glycosylated form (5) .
No differences in the biological activities of the glycosylated (natural) and nonglycosylated (recombinant) forms of IL-2 have been observed in vitro (26, 30) , but no reports of in vivo differences have been published. Now that we have obtained several high-producer cell lines of IL-2, it will be possible to purify glycosylated as well as non-glycosylated IL-2, and to compare their physiological properties and therapeutic values. The application of proper promoter-vector and gene amplification systems in animal cells by using recombinant DNA technology will be able to support the establishment of high-producer cell lines of useful proteins and to contribute to their study and use.
